Literature DB >> 20056925

Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment.

Alex Zacharek1, Amjad Shehadah, Jieli Chen, Xu Cui, Cynthia Roberts, Mei Lu, Michael Chopp.   

Abstract

BACKGROUND AND
PURPOSE: We compared the effect of treatment of stroke with bone marrow stromal cells from stroke rats (Isch-BMSC) and normal rats (Nor-BMSC) on functional outcome.
METHODS: Isch-BMSCs and Nor-BMSCs were intravenously injected into rats 24 hours after middle cerebral artery occlusion. To test the mechanism of Isch-BMSC-enhanced neurorestoration, Isch-BMSC and Nor-BMSC cultures were used.
RESULTS: Isch-BMSC significantly promoted functional outcome and enhanced angiogenesis, arterial density, and axonal regeneration compared with Nor-BMSC treatment animals. Isch-BMSCs exhibited increased Angiopoietin-1, Tie2, basic fibroblast growth factor, glial cell-derived neurotrophic factor, vascular endothelial growth factor, and Flk1 gene expression compared with Nor-BMSC. Using transwell coculture of BMSCs with brain-derived endothelial cells, Isch-BMSCs increased phosphorylated-Tie2 activity in brain-derived endothelial cells and enhanced brain-derived endothelial cells capillary tube formation compared with Nor-BMSCs. Inhibition of Tie2 gene expression in brain-derived endothelial cells using siRNA significantly attenuated BMSC-induced capillary tube formation.
CONCLUSIONS: These data suggest that Isch-BMSCs are superior to Nor-BMSCs for the neurorestorative treatment of stroke, which may be mediated by the enhanced trophic factor and angiogenic characteristics of Isch-BMSCs.

Entities:  

Mesh:

Year:  2010        PMID: 20056925      PMCID: PMC2847444          DOI: 10.1161/STROKEAHA.109.568881

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

1.  Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats.

Authors:  Li-Ru Zhao; Wei-Ming Duan; Morayma Reyes; C Dirk Keene; Catherine M Verfaillie; Walter C Low
Journal:  Exp Neurol       Date:  2002-03       Impact factor: 5.330

2.  Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.

Authors:  Alex Zacharek; Jieli Chen; Xu Cui; Ang Li; Yi Li; Cynthia Roberts; Yifan Feng; Qi Gao; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2007-03-14       Impact factor: 6.200

3.  Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats.

Authors:  Jieli Chen; Zheng Gang Zhang; Yi Li; Lei Wang; Yong Xian Xu; Subhash C Gautam; Mei Lu; Zhenping Zhu; Michael Chopp
Journal:  Circ Res       Date:  2003-02-27       Impact factor: 17.367

4.  Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats.

Authors:  J Chen; Y Li; L Wang; Z Zhang; D Lu; M Lu; M Chopp
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

5.  Injection of neural progenitor cells improved learning and memory dysfunction after cerebral ischemia.

Authors:  Nobuyuki Mochizuki; Norio Takagi; Koji Kurokawa; Chika Onozato; Yoshiyuki Moriyama; Kouichi Tanonaka; Satoshi Takeo
Journal:  Exp Neurol       Date:  2008-02-16       Impact factor: 5.330

6.  Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells.

Authors:  Kazuya Takahashi; Takao Yasuhara; Tetsuro Shingo; Kenichiro Muraoka; Masahiro Kameda; Akira Takeuchi; Akimasa Yano; Kazuhiko Kurozumi; Takashi Agari; Yasuyuki Miyoshi; Kazushi Kinugasa; Isao Date
Journal:  Brain Res       Date:  2008-07-30       Impact factor: 3.252

7.  Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells.

Authors:  Ivana Rosová; Mo Dao; Ben Capoccia; Daniel Link; Jan A Nolta
Journal:  Stem Cells       Date:  2008-05-29       Impact factor: 6.277

8.  Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct.

Authors:  Hanna Kozłowska; Jan Jabłonka; Miroslaw Janowski; Marcin Jurga; Malgorzata Kossut; Krystyna Domańska-Janik
Journal:  Stem Cells Dev       Date:  2007-06       Impact factor: 3.272

9.  A simple method for isolation and characterization of mouse brain microvascular endothelial cells.

Authors:  Zhenhua Wu; Florence M Hofman; Berislav V Zlokovic
Journal:  J Neurosci Methods       Date:  2003-11-30       Impact factor: 2.390

10.  eNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in mice.

Authors:  Jieli Chen; Xu Cui; Alex Zacharek; Cynthia Roberts; Michael Chopp
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

View more
  36 in total

Review 1.  Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke.

Authors:  Huan Wan; Fangqin Li; Lei Zhu; Jing Wang; Zizhen Yang; Yujun Pan
Journal:  J Mol Neurosci       Date:  2013-09-19       Impact factor: 3.444

Review 2.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

3.  Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats.

Authors:  Ling Wei; Jamie L Fraser; Zhong-Yang Lu; Xinyang Hu; Shan Ping Yu
Journal:  Neurobiol Dis       Date:  2012-03-09       Impact factor: 5.996

4.  Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke.

Authors:  Bing Yang; Xiaopei Xi; Jaroslaw Aronowski; Sean I Savitz
Journal:  Stem Cells Dev       Date:  2012-08-03       Impact factor: 3.272

5.  Bone marrow-derived cells contribute to vascular endothelial growth factor-induced angiogenesis in the adult mouse brain by supplying matrix metalloproteinase-9.

Authors:  Qi Hao; Hua Su; Daniel Palmer; Baoliang Sun; Peng Gao; Guo-Yuan Yang; William L Young
Journal:  Stroke       Date:  2010-12-16       Impact factor: 7.914

6.  MiR-126 Mediates Brain Endothelial Cell Exosome Treatment-Induced Neurorestorative Effects After Stroke in Type 2 Diabetes Mellitus Mice.

Authors:  Poornima Venkat; Chengcheng Cui; Michael Chopp; Alex Zacharek; Fengjie Wang; Julie Landschoot-Ward; Yi Shen; Jieli Chen
Journal:  Stroke       Date:  2019-08-09       Impact factor: 7.914

7.  Stroke Induces Mesenchymal Stem Cell Migration to Infarcted Brain Areas Via CXCR4 and C-Met Signaling.

Authors:  Oh Young Bang; Gyeong Joon Moon; Dong Hee Kim; Ji Hyun Lee; Sooyoon Kim; Jeong Pyo Son; Yeon Hee Cho; Won Hyuk Chang; Yun-Hee Kim
Journal:  Transl Stroke Res       Date:  2017-05-25       Impact factor: 6.829

Review 8.  Bone marrow stromal cells as a therapeutic treatment for ischemic stroke.

Authors:  Zizhen Yang; Lei Zhu; Fangqin Li; Jing Wang; Huan Wan; Yujun Pan
Journal:  Neurosci Bull       Date:  2014-05-10       Impact factor: 5.203

Review 9.  Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.

Authors:  Mark A Eckert; Quynh Vu; Kate Xie; Jingxia Yu; Wenbin Liao; Steven C Cramer; Weian Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-12       Impact factor: 6.200

10.  Adipose-tissue derived porcine mesenchymal stem cells efficiently ameliorate CCl4-induced acute liver failure in mice.

Authors:  Shourong Liu; Ruihong Guo; Xiaoli Hou; Yue Zhang; Xiawei Jiang; Tiantian Wang; Xiaoyu Wu; Keyang Xu; Xiaoping Pan; Liang Qiao
Journal:  Cytotechnology       Date:  2020-04-25       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.